Position in CADL
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$618,000
New position
Shares Held
60,000
first reported quarter
Ownership
0.082%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#3
of 16 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026COOKSON PEIRCE & CO INC holds $47,400,065 across 10 Biotechnology names. CADL ranks #8 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
398,854 | $22,363,743 | |
| 2 | INCY |
Incyte Corp
|
126,885 | $14,383,683 | |
| 3 | LGND |
Ligand Pharmaceuticals Inc
|
11,822 | $3,736,815 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
4,898 | $1,820,439 | |
| 5 | AUPH |
Aurinia Pharmaceuticals Inc.
|
104,992 | $1,781,714 | |
| 6 | LEGN |
Legend Biotech Corp
|
30,000 | $866,400 | |
| 7 | ABCL |
AbCellera Biologics Inc.
|
100,000 | $785,000 | |
| 8 | CADL |
Candel Therapeutics, Inc.
This page
|
60,000 | $618,000 |
All Filings in CADL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $618,000 | 60,000 | Shares | Sole | 2026-07-23 | |
| No filing history on record for this holder in this stock. | ||||||